U.S. markets close in 5 hours 59 minutes

Trinity Biotech plc (TRIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.8200-0.0600 (-1.55%)
As of 9:55AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/12/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
78.38M79.64M42.22M45.57M22.99M
Enterprise Value 3
134.94M142.79M109.55M131.34M79.77M
Trailing P/E
6.28N/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
0.971.090.620.620.30
Price/Book (mrq)
N/A11.26N/A59.330.59
Enterprise Value/Revenue 3
1.324.363.428.203.77
Enterprise Value/EBITDA 7
6.6215.7512.05261.1046.27

Trading Information

Stock Price History

Beta (5Y Monthly) 1.72
52-Week Change 3259.26%
S&P500 52-Week Change 345.08%
52 Week High 36.8200
52 Week Low 31.0100
50-Day Moving Average 34.3077
200-Day Moving Average 33.9827

Share Statistics

Avg Vol (3 month) 3537.29k
Avg Vol (10 day) 3230.43k
Shares Outstanding 520.9M
Implied Shares Outstanding 6N/A
Float 16.72M
% Held by Insiders 120.27%
% Held by Institutions 127.61%
Shares Short (Mar 30, 2021) 4364.91k
Short Ratio (Mar 30, 2021) 40.91
Short % of Float (Mar 30, 2021) 4N/A
Short % of Shares Outstanding (Mar 30, 2021) 4N/A
Shares Short (prior month Feb 25, 2021) 4258.09k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jun 30, 2015
Ex-Dividend Date 4Jun 04, 2015
Last Split Factor 21:4
Last Split Date 3Jun 01, 2005

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin -6.26%
Operating Margin (ttm)18.13%

Management Effectiveness

Return on Assets (ttm)8.84%
Return on Equity (ttm)-512.27%

Income Statement

Revenue (ttm)101.98M
Revenue Per Share (ttm)4.88
Quarterly Revenue Growth (yoy)53.70%
Gross Profit (ttm)48.58M
EBITDA 21.59M
Net Income Avi to Common (ttm)-6.39M
Diluted EPS (ttm)-0.3060
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)27.33M
Total Cash Per Share (mrq)1.31
Total Debt (mrq)100.5M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.08
Book Value Per Share (mrq)-0.11

Cash Flow Statement

Operating Cash Flow (ttm)28.29M
Levered Free Cash Flow (ttm)10.97M